DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Lee YG. et al.
Cisplatin-based chemotherapy is a strong risk factor for thromboembolic events in small-cell lung cancer.
Cancer Res Treat 2015;
47: 670-675.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.